2nd Circ. Backs Aetna In Brand-Name Drug Coverage Fight
By Patrick Hoff · April 25, 2022, 4:34 PM EDT
The Second Circuit has ruled that Aetna did not violate federal benefits law when it refused to reimburse an insured for her brand-name antidepressant, saying it should have been clear that...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login